Fabrazyme Genzyme Corp - Treatment for Fabry Disease
Fabrazyme is a recombinant form of human alpha-galactosidase A, administered intravenously for the treatment of Fabry Disease.Posted: April 2003
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
